Literature DB >> 28729454

Multimodal Regulation of Cardiac Myocyte Proliferation.

Xuejun Yuan1, Thomas Braun2.   

Abstract

Efficient cardiac regeneration is closely associated with the ability of cardiac myocytes to proliferate. Fetal or neonatal mouse hearts containing proliferating cardiac myocytes regenerate even extensive injuries, whereas adult hearts containing mostly post-mitotic cardiac myocytes have lost this ability. The same correlation is seen in some homoiotherm species such as teleost fish and urodelian amphibians leading to the hypothesis that cardiac myocyte proliferation is a major driver of heart regeneration. Although cardiomyocyte proliferation might not be the only prerequisite to restore full organ function after cardiac damage, induction of cardiac myocyte proliferation is an attractive therapeutic option to cure the injured heart and prevent heart failure. To (re)initiate cardiac myocyte proliferation in adult mammalian hearts, a thorough understanding of the molecular circuitry governing cardiac myocyte cell cycle regulation is required. Here, we review the current knowledge in the field focusing on the withdrawal of cardiac myocytes from the cell cycle during the transition from neonatal to adult stages.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  cell cycle; epigenomics; genes; myocytes, cardiac; regeneration

Mesh:

Year:  2017        PMID: 28729454     DOI: 10.1161/CIRCRESAHA.117.308428

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  34 in total

1.  Cardiomyocyte cell cycle dynamics and proliferation revealed through cardiac-specific transgenesis of fluorescent ubiquitinated cell cycle indicator (FUCCI).

Authors:  Roberto Alvarez; Bingyan J Wang; Pearl J Quijada; Daniele Avitabile; Thi Ho; Maya Shaitrit; Monica Chavarria; Fareheh Firouzi; David Ebeid; Megan M Monsanto; Natalie Navarrete; Maryam Moshref; Sailay Siddiqi; Kathleen M Broughton; Barbara A Bailey; Natalie A Gude; Mark A Sussman
Journal:  J Mol Cell Cardiol       Date:  2018-12-18       Impact factor: 5.000

2.  Inhibition of mTOR Signaling Enhances Maturation of Cardiomyocytes Derived From Human-Induced Pluripotent Stem Cells via p53-Induced Quiescence.

Authors:  Jessica C Garbern; Aharon Helman; Rebecca Sereda; Mohsen Sarikhani; Aishah Ahmed; Gabriela O Escalante; Roza Ogurlu; Sean L Kim; John F Zimmerman; Alexander Cho; Luke MacQueen; Vassilios J Bezzerides; Kevin Kit Parker; Douglas A Melton; Richard T Lee
Journal:  Circulation       Date:  2019-11-11       Impact factor: 29.690

3.  Genetic insights into mammalian heart regeneration.

Authors:  Ana Vujic; Vinícius Bassaneze; Richard T Lee
Journal:  Nat Genet       Date:  2017-08-30       Impact factor: 38.330

4.  Induction of cardiomyocyte proliferation and angiogenesis protects neonatal mice from pressure overload-associated maladaptation.

Authors:  Mona Malek Mohammadi; Aya Abouissa; Isyatul Azizah; Yinuo Xie; Julio Cordero; Amir Shirvani; Anna Gigina; Maren Engelhardt; Felix A Trogisch; Robert Geffers; Gergana Dobreva; Johann Bauersachs; Joerg Heineke
Journal:  JCI Insight       Date:  2019-07-23

Review 5.  Adult Cardiomyocyte Cell Cycle Detour: Off-ramp to Quiescent Destinations.

Authors:  Kathleen M Broughton; Mark A Sussman
Journal:  Trends Endocrinol Metab       Date:  2019-06-28       Impact factor: 12.015

Review 6.  Cardiomyocyte Proliferation from Fetal- to Adult- and from Normal- to Hypertrophy and Failing Hearts.

Authors:  Sanford P Bishop; Jianyi Zhang; Lei Ye
Journal:  Biology (Basel)       Date:  2022-06-08

Review 7.  Polyploidy in liver development, homeostasis and disease.

Authors:  Romain Donne; Maëva Saroul-Aïnama; Pierre Cordier; Séverine Celton-Morizur; Chantal Desdouets
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-04-02       Impact factor: 46.802

8.  Inhibiting the Pkm2/b-catenin axis drives in vivo replication of adult cardiomyocytes following experimental MI.

Authors:  Ludger Hauck; Keith Dadson; Shelly Chauhan; Daniela Grothe; Filio Billia
Journal:  Cell Death Differ       Date:  2020-12-07       Impact factor: 15.828

9.  Low-dose Dasatinib Ameliorates Hypertrophic Cardiomyopathy in Noonan Syndrome with Multiple Lentigines.

Authors:  Jae-Sung Yi; Sravan Perla; Yan Huang; Kana Mizuno; Frank J Giordano; Alexander A Vinks; Anton M Bennett
Journal:  Cardiovasc Drugs Ther       Date:  2021-03-10       Impact factor: 3.947

10.  San1 deficiency leads to cardiomyopathy due to excessive R-loop-associated DNA damage and cardiomyocyte hypoplasia.

Authors:  Zhiheng Liu; Xu Gao; Zhou Zhou; Sung Wook Kang; Yong Yang; Hao Liu; Chunqin Zhang; Zheng Wen; Xiaoquan Rao; Daowen Wang; Donnell White; Qinglin Yang; Qinqiang Long
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-07-31       Impact factor: 5.187

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.